Coagulopathy as a presenting feature of Wilms tumour

Abstract

we emphasise the importance of a routine coagulation screen in every patient who presents with a possible Wilms' tumour.

Interpretive Limitations Associated With Plasma Volume Shifts in the Clinical Assessment of Hemostasis

“…Furthermore, ''significant'' shortening from baseline to uncorrected values was reported as 33.1 T 0.8 second, which is comfortably within the boundaries of a normal aPTT (5). Furthermore, ''significant'' shortening from baseline to uncorrected values was reported as 33.1 T 0.8 second, which is comfortably within the boundaries of a normal aPTT (5).…”

13-cis Retinoic Acid Treatment of a Patient With Chemotherapy Refractory Nephroblastomatosis

“…21 Taken together, we observed a remarkable response to retinoic acid in a patient with bilateral nephroblastomatosis refractory to chemotherapy. We suggest that retinoic acid should be systematically investigated in patient with the disease in a prospective trial in combination with standard chemotherapy.…”

Acquired von Willebrand syndrome: An update

“…Most cases of myeloproliferative disorders associated with aVWS are essential thrombocythemia [37][38][39][40][41][42][43][44][45][46][47], while polycythemia vera [48] and chronic myeloid leukemia [49][50][51] are less frequent. The second most common groups of disorders associated with aVWS is neoplasia, including Wilms tumors [52][53][54][55][56][57] and carcinomas [58,59], followed by immunological diseases, most notably SLE [14,60,61] and hypothyroidism [62][63][64][65][66][67][68][69][70][71][72][73][74][75]. Various other clinical conditions (Table I), such as rare immunological disorders [76][77][78][79], cardiovascular diseases [80][81]…”